Moritz Spangemacher
@moeswisdom.bsky.social
📤 125
📥 176
📝 2
Physician & Researcher @zi_mannheim Podcast: @gottundloeffel
reposted by
Moritz Spangemacher
Max Wolff
8 days ago
Strong alliance, weak conclusions: Comment on Goodwin et al. (2026) “The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression”
osf.io/preprints/ps...
Many thanks to my coauthors Rick Zeifman,
@kangaslampi.bsky.social
&
@moeswisdom.bsky.social
loading . . .
OSF
https://osf.io/preprints/psyarxiv/8s7xk_v1
1
6
3
reposted by
Moritz Spangemacher
Tom Taylor
9 months ago
What a headline.
244
27049
6498
NY Times Ballot - Best Movies of the Century so far
10 months ago
0
1
0
reposted by
Moritz Spangemacher
Max Wolff
10 months ago
Reframing Psychedelic Regulation: Tools, not Treatments In this new article, we propose to regulate psychedelics as psychotherapeutic treatment tools rather than as treatments in their own right. The use of anesthetics as treatment tools in surgery is a useful analogy.
2
24
10
reposted by
Moritz Spangemacher
Matt Wall
11 months ago
🚨🚨New psychedelics paper out today! 🚨🚨 "Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression."
psychiatryonline.org/doi/10.1176/...
🧵⬇️
loading . . .
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression | American Journal of Psychiatry
Objective: Psilocybin is an emerging intervention for depression that may be at least as effective as selective serotonin reuptake inhibitors (SSRIs), but effects of the two treatments on the neural c...
https://psychiatryonline.org/doi/10.1176/appi.ajp.20230751
2
15
10
reposted by
Moritz Spangemacher
Awais Aftab
11 months ago
My opinion piece in today’s
@nytimes.com
. I discuss how clinical neglect of medication-related harms has made RFK Jr’s stance on antidepressants appealing to so many and moving the public conversation in a productive direction requires us to remedy this neglect.
www.nytimes.com/2025/05/03/o...
loading . . .
Opinion | What Kennedy Gets Right, And Wrong, About Antidepressants (Gift Article)
Harm from these drugs is real. Let’s not cede the conversation to Kennedy.
https://www.nytimes.com/2025/05/03/opinion/antidepressants-withdrawal-rfk.html?unlocked_article_code=1.EU8.rXiu.iBIw3kAQyXeo&smid=nytcore-ios-share&referringSource=articleShare
9
76
42
reposted by
Moritz Spangemacher
eLife
about 1 year ago
Research is investigating the medicinal applications of
#psilocybin
, with studies showing how
#psychedelics
can promote neuronal plasticity. This ‘fundamental’ study into the effects of
#psilocin
on human neurons:
buff.ly/f7cNemV
0
14
8
reposted by
Moritz Spangemacher
Rich Haridy
about 1 year ago
Another null result psychedelic trial. This time looking at LSD microdosing for ADHD. Most interesting is the detail showing most subjects in LSD group correctly guessed they got the psychedelic. BUT their benefits still mostly matched the placebo group.
loading . . .
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults
This double-blind, placebo-controlled randomized clinical trial determines the safety and efficacy of repeated low doses of lysergic acid diethylamide (LSD) in reducing attention-deficit/hyperactivity...
https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2831639?guestAccessKey=23c31ddb-7254-4b22-b935-1a20aef7b816&utm_source=linkedin_company&utm_medium=social_jamapsyc&utm_term=16429026237&utm_campaign=article_alert&linkId=777551010
2
6
5
reposted by
Moritz Spangemacher
Dino Luethi
about 1 year ago
A recent study suggests that no dose adjustment of
#LSD
is necessary in the presence of an SSRI that inhibits CYP2D6.
#psychedelics
ascpt.onlinelibrary.wiley.com/doi/10.1002/...
loading . . .
Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre‐Administration in a Randomized, Double‐Blind, Cross‐Over Phase I Trial
Psychedelics, such as psilocybin and lysergic acid diethylamide (LSD), are being investigated for the treatment of depressive and anxiety disorders, for which concomitant treatment with selective ser...
https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.3618?af=R
0
3
1
This cause is close to my heart - please sign:
weact.campact.de/petitions/sc...
loading . . .
Schluss mit dem Angriff auf NGOs und Medien! Keine Zensur durch die CDU!
Nur einen Tag nach der Wahl hat die CDU/CSU-Fraktion eine Anfrage eingereicht, die gezielt NGOs und kritische Medien ins Visier nimmt. Einen Tag zuvor nannte Friedrich Merz Demonstranten gegen Rechts ...
https://weact.campact.de/petitions/schluss-mit-dem-angriff-auf-ngos-und-medien-keine-zensur-durch-die-cdu?source=bluesky-share-button&utm_medium=recommendation&utm_source=bluesky&share=013ee727-1ab9-46be-8377-a08863c9abe5
about 1 year ago
0
1
0
reposted by
Moritz Spangemacher
arno
about 1 year ago
Wir alle, Robert, wir alle
loading . . .
36
5244
920
reposted by
Moritz Spangemacher
Mario Sixtus
about 1 year ago
Wenig überraschend ist die größte inhaltliche Übereinstimmung der CDU mit einer anderen Partei, die, mit der AfD. Das macht gemeinsames Abstimmen natürlich mindestens verlockend und lässt es ganz natürlich erscheinen.
www.spiegel.de/politik/wahl...
14
517
166
reposted by
Moritz Spangemacher
Jules Evans
about 1 year ago
First suicide in legal PAT, in Switzerland (first known case out of around 2000). History of delusions could be a red flag, not clear what the previous delusions and how psychosis-like they were. Thanks to the team for publishing this.
www.sciencedirect.com/science/arti...
loading . . .
Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case report
https://www.sciencedirect.com/science/article/pii/S0165178125000307
0
8
2
reposted by
Moritz Spangemacher
david ehrlich
about 1 year ago
THE 25 BEST FILMS OF 2024 A video countdown
vimeo.com/1046284152
113
2590
897
reposted by
Moritz Spangemacher
Lea Mertens
over 1 year ago
Glad to be at
#ACNP2024
in Phoenix! On Monday, I will be presenting the results of our episode trial in the session „Psychedelic-assisted Psychotherapy: From preclinical mechanisms to clinical applications“ alongside
@fredbarrettphd.bsky.social
,
@kellietamashiro.bsky.social
and Jennifer Mitchell.
0
8
3
you reached the end!!
feeds!
log in